Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 46 EP applications Julie Carlisle has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11751256

MOLECULARLY IMPRINTED CARBON

IPC classification:
C01B 31/02
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11760242

COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION

IPC classification:
A01N 31/00, A61K 31/045
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11843945

INTEGRIN-LINKED KINASE INHIBITORS

IPC classification:
A01N 43/56, A61K 31/415
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175481

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07B 43/04, C07D 213/61, C07D 401/06, C07D 401/14
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175480

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07B 43/04, C07D 213/61, C07D 401/06, C07D 401/14
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13174255

Plant disease control agent

IPC classification:
A01N 59/20, A01N 37/34, A01N 37/46, A01N 43/36, A01N 43/50, A01N 43/54, A01N 43/653, A01N 43/713, A01N 47/04, A01N 47/12, A01N 47/18, A01N 47/34, A01N 47/44, A01N 51/00, A01N 55/02, A01N 57/12, A01P 3/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP12749942

USE OF TEMPLATE SWITCHING FOR DNA SYNTHESIS

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12760881

AQUEOUS HORTICULTURAL MICROBICIDAL COMPOSITION SUSPENSION

IPC classification:
A01N 25/04, A01N 25/30, A01N 43/713, A01P 3/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12781697

LIQUID INSECTICIDE COMPOSITION

IPC classification:
A01N 25/02, A01N 25/30, A01N 47/40, A01P 7/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12815454

RUTHENIUM CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF

IPC classification:
A01N 55/02, A01N 59/04, A61K 39/40
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11821298

RECORDING MATERIAL USING PHENOL COMPOUND

IPC classification:
B41M 5/155, B41M 5/333, C07C 231/02, C07C 233/07, C07C 233/11
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11838597

ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES

IPC classification:
A61P 31/04, C07D 231/12, C07D 405/04, C07D 471/04, A61K 31/415, A61K 31/4155, A61K 31/5415
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP11800415

NOVEL COPOLYMER

IPC classification:
B01F 17/16, B01F 17/18, B01F 17/52, C08F 297/02, C09D 11/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12836312

METHOD FOR PRODUCING ELECTRODE COVERED WITH SODIUM METAL

IPC classification:
C23C 2/04, C23C 14/14, C23C 26/00, H01M 4/134, H01M 4/1395
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12838482

SILYLATED POLYBUTADIENE

IPC classification:
C08F 8/00, C08F 36/06, C08K 5/14, C08L 47/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12834802

INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS

IPC classification:
G01N 24/00
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12841303

NOVEL COPOLYMER

IPC classification:
C08F 297/02, C09B 67/20, G02B 5/20
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12175020

Method for identifying pI3-kinase antagonists

IPC classification:
A61P 35/00, A61P 35/04, C07D 487/04, A61K 31/519
Applicant:
University of California
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12850965

PHOTOCATALYST-SUPPORTING STRUCTURE

IPC classification:
B01J 35/02, B32B 7/12, B32B 9/00, B32B 27/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11705962

METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF 4-OXO-3,4-DIHYDRO-IMIDAZO[5,1-D][1,2,3,5]TETRAZINES

IPC classification:
C07D 487/04
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13782216

DR5 LIGAND DRUG CONJUGATES

IPC classification:
A61K 39/395
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182732

Auristatin drug linker conjugates

IPC classification:
C07K 5/02, A61K 38/00, A61K 47/48
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14185157

Thioninium compounds and their use

IPC classification:
A61P 25/28, A61K 31/5415
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13804801

METHOD FOR PRODUCING AZIDE COMPOUND, AND METHOD FOR PRODUCING 1H-TETRAZOLE DERIVATIVE

IPC classification:
C07C 247/04, C07D 257/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13813323

COMPOSITION CONTAINING BIOLOGICALLY ACTIVE SUBSTANCE

IPC classification:
A61P 1/00, A23K 1/16, A23K 1/18, A61K 9/42, A61K 31/198, A61K 45/00, A61K 47/12, A61K 47/42
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13816684

ORGANIC-INORGANIC COMPLEX, AND FORMING COMPOSITION THEREOF

IPC classification:
B32B 9/00, C07F 7/18, C08K 5/5419, C08L 83/04, C08L 101/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13819250

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13820351

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13831167

TREATMENT OF SICKLE CELL DISEASE AND INFLAMMATORY CONDITIONS

IPC classification:
A61P 3/00, A61P 7/00, A61K 31/7004, A61K 31/7024, A61K 31/7048
Applicant:
Seattle Genetics, Inc.
Applicant:
Regents of the University of Minnesota
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759274

FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE

IPC classification:
A61P 35/00, C07D 413/10, C07D 417/10, C07D 417/14, A61K 31/427, A61K 31/4439
Applicant:
The Institute of Cancer Research - Royal Cancer Hospital
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13833806

EXTRACTION METHOD

IPC classification:
B01D 11/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13834929

PLANT GROWTH ACCELERATOR

IPC classification:
A01N 25/00, A01N 43/653, A01P 21/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13845276

ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS

IPC classification:
A61K 49/06
Applicant:
Case Western Reserve University
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11804267

BIOSECURE GENETICALLY MODIFIED ALGAE

IPC classification:
C12N 1/12
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849834

MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB

IPC classification:
C07D 277/00, A61K 38/06
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11748458

TRANS-EPITHELIAL OSMOTIC COLLYRIUM FOR THE TREATMENT OF KERATOCONUS

IPC classification:
A61P 27/02, A61K 9/08, A61K 31/14, A61K 31/525
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION REFUSED
EP11751155

METHODS FOR SCREENING ANTIBODIES

IPC classification:
C07K 16/00, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11768603

NOVEL COPOLYMER

IPC classification:
B01F 17/00, C08F 297/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12744261

SUGAR EXTRACTS

IPC classification:
A61P 3/04, C13K 13/00, A23K 1/02, A23K 1/16, A23K 1/18, A23L 1/29, A23L 1/30, A23L 1/307
Agent:
Julie Carlisle, Mewburn Ellis LLP
Agent:
Stéphane Agasse, Cabinet Germain & Maureau
Status:
EXAMINATION REQUESTED
EP14789349

METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC)

IPC classification:
C07D 279/18
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14802705

SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS

IPC classification:
A61P 5/44, C07J 41/00, C07J 43/00, A61K 31/56, A61K 31/58
Applicant:
University of Manchester
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13171810

Alkylated heterocyclic reaction products useful as antioxidants

IPC classification:
C07C 39/16, C07C 213/08, C07C 215/74, C07D 307/42, C07D 333/16, C07D 333/18, C08K 5/13, C08K 5/18, C08K 5/3415, C08K 5/47, C10M 129/20, C10M 135/34, C10M 149/14, C10M 159/12
Applicant:
Albemarle Corporation
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15743124

METHODS OF TREATING AND IMAGING TUMOR MICROMETASTASES USING PHOTOACTIVATABLE IMMUNOCONJUGATES

IPC classification:
G01J 1/48, A61K 41/00, A61K 49/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15174121

PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER

IPC classification:
A61K 49/00, A61K 49/10
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15766414

QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS

IPC classification:
A61P 35/00, C07D 215/36, C07D 215/38, A61K 31/4704
Applicant:
UCL Business plc
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made
EP15839387

CRYSTAL POLYMORPHISM OF INCLUSION COMPOUND AND METHOD FOR PRODUCING SAME, AND CURABLE RESIN COMPOSITION

IPC classification:
C07C 37/84, C07C 39/15, C07D 233/64, C08G 59/40, C08G 59/62
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature